Modified corneal collagen crosslinking reduces corneal oedema and diurnal visual fluctuations in Fuchs dystrophy.
Hafezi
Farhad
F
IROC, Institute for Refractive and Ophthalmic Surgery, Stockerstrasse 37, Zurich 8002, Switzerland. farhad@hafezi.ch
Dejica
Peter
P
Majo
Francois
F
D002940:Circadian Rhythm / Q000502:physiology; D003094:Collagen / Q000378:metabolism*; D003315:Cornea / Q000378:metabolism*; D015715:Corneal Edema / Q000378:metabolism / Q000628:therapy*; D003432:Cross-Linking Reagents / Q000627:therapeutic use; D005260:Female; D005642:Fuchs' Endothelial Dystrophy / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D014792:Visual Acuity / Q000502:physiology
D003432:Cross-Linking Reagents; D003094:Collagen